Xylem (XYL) Stock Forecast & Price Target

Xylem demonstrated a robust growth trajectory in its financial performance, with 3Q25 revenues reaching $656.0 million, representing a 5.3% year-over-year increase driven by strong demand and effective backlog execution. The company's organic revenue growth has stabilized in the mid-single digits, recovering from pandemic-related challenges, and shows promise of further improvement through the successful integration of Evoqua, which is expected to enhance its growth profile. Additionally, margin expansion of 200 basis points reflects significant operating performance improvements, positioning Xylem favorably within the water technology sector.

Xylem's outlook appears negative due to expected challenges in both revenue and earnings per share (EPS), with 2026 EPS guidance falling slightly below consensus, signaling potential investor concerns. The company faces continued softness in the Chinese market, which is anticipated to exert pressure on its Water Infrastructure and Applied Water segments, along with a slower revenue start in 1Q26 attributed to competitive forces and delayed project timelines. Additionally, the ongoing implementation of the 80/20 rationalization strategy is expected to dampen overall segment growth, contributing to a cautious near-term outlook for the company's earnings and revenue trajectory.